Showing 1411-1420 of 7023 results for "".
Dermatologists as Comprehensive Skin Solution Providers
https://practicaldermatology.com/series/c-suite-chats/dermatologists-comprehensive-skin-solution-providers/30063/Mark Steele, President of Nuance Medical, discusses the need for dermatologists to serve as comprehensive skin solution providers, and how the recent acquisition of Biocorneum will help meet consumer demands.Science of Skincare Summit 2024: Social Media as Education Tool
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-social-media-as-education-tool/29448/Jennifer Liu, MD, a dermatologist and social media influencer (dermfluencer) talks with Practical Dermatology about using social media at a tool to educate various audiences with correct information about both products and conditions such as atopic dermatitis and psoriasis. This video was recorded aInnovations in the Aesthetic Market and Wrinkle Removal Technology
https://practicaldermatology.com/series/c-suite-chats/innovations-aesthetic-market-and-wrinkle-removal-technology/26732/Lou Scafuri, CEO of SofWave Medical, talks about what makes the company’s Synchronous Ultrasound Parallel Beam technology unique.FDA Approves New AD Treatment; Study Examines Omega-3 Fatty Acids in Managing Acne
https://practicaldermatology.com/series/dermwire-tv/fda-approves-new-ad-treatment-study-examines-omega-3-fatty-acids-managing-acne/26664/In this week’s DermwireTV, a new steroid-free treatment option for children and adults living with AD is approved by the FDA; research examines the potential benefits of omega-3 fatty acids in managing acne severity; Modern Aesthetics announces plans to relaunch its news broadcast; and Andrew MastroTo Sell or Not to Sell to Private Equity?
https://practicaldermatology.com/conferences/scale-2023/to-sell-or-not-to-sell-to-private-equity/20195/Joel L. Cohen, MD, and George Hruza MD, discuss the pros and cons of selling to private equity. Pros include back-office support and better pricing on technology and supplies, while cons can include giving up autonomy.Social Media Success Strategies
https://practicaldermatology.com/topics/practice-management/social-media-success-strategies/20191/Doris Day, MD, shares some best practices on using social media to educate patients and dispel myths perpetuated by ‘skinfluencers’.DermWireTV: Spevigo for GPP; Derms on Acne Experience; IFPA Takes PsO to the Gaming World; La Roche-Posay at the US Open
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-spevigo-for-gpp-derms-on-acne-experience-ifpa-takes-pso-to-the-gaming-world-la-roche-posay-at-the-us-open/20136/Boehringer Ingelheim’s Spevigo is the first FDA-approved treatment option for generalized pustular psoriasis (GPP) flares in adults. Spesolimab is a novel, selective antibody that blocks the activation of the interleukin-36 receptor. Dermatologists, dermatology physician assistants, and dermatologyWhat’s the Latest in Hair Management?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/whats-the-latest-in-hair-management/20113/Chytra Anand, MD, Neil Sadick, MD, and Brooke Jackson, MD offer insights on the best approaches to managing hair from global clinical experience to strategies for understanding the needs of each individual patient, they share tips to improve clinical outcomes.Exploring High-Dose Neurotoxin Injections
https://practicaldermatology.com/conferences/maui-derm-2022/exploring-high-dose-neurotoxin-injections/20055/Michael H. Gold, MD shares his thoughts on the potential benefits of high-dose neurotoxin injections for some patients. He discusses his experience and the kind of results he's been able to achieve.Winning Combinations in Cosmetic Dermatology
https://practicaldermatology.com/conferences/maui-derm-2022/winning-combinations-in-cosmetic-dermatology/20280/When it comes to ensuring the best results possible for aesthetic treatments, Suneel Chilukuri, MD says combinations are key. He discusses his approach for patients using neurotoxins, fillers, and devices.